These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 19380411

  • 1. Role of 18F-FDG PET in assessment of response in non-small cell lung cancer.
    Hicks RJ.
    J Nucl Med; 2009 May; 50 Suppl 1():31S-42S. PubMed ID: 19380411
    [Abstract] [Full Text] [Related]

  • 2. PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.
    Keidar Z, Haim N, Guralnik L, Wollner M, Bar-Shalom R, Ben-Nun A, Israel O.
    J Nucl Med; 2004 Oct; 45(10):1640-6. PubMed ID: 15471827
    [Abstract] [Full Text] [Related]

  • 3. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1432-41. PubMed ID: 16125870
    [Abstract] [Full Text] [Related]

  • 4. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun 01; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of serial [18F]fluorodeoxyglucose PET-CT uptake in stage III patients with non-small cell lung cancer treated by concurrent chemoradiotherapy.
    Zhang HQ, Yu JM, Meng X, Yue JB, Feng R, Ma L.
    Eur J Radiol; 2011 Jan 01; 77(1):92-6. PubMed ID: 19695804
    [Abstract] [Full Text] [Related]

  • 6. Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.
    Everitt S, Hicks RJ, Ball D, Kron T, Schneider-Kolsky M, Walter T, Binns D, Mac Manus M.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1098-104. PubMed ID: 19386444
    [Abstract] [Full Text] [Related]

  • 7. Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).
    Miele E, Spinelli GP, Tomao F, Zullo A, De Marinis F, Pasciuti G, Rossi L, Zoratto F, Tomao S.
    J Exp Clin Cancer Res; 2008 Oct 17; 27(1):52. PubMed ID: 18928537
    [Abstract] [Full Text] [Related]

  • 8. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
    Vinod SK, Kumar S, Holloway LC, Shafiq J.
    J Med Imaging Radiat Oncol; 2010 Apr 17; 54(2):152-60. PubMed ID: 20518880
    [Abstract] [Full Text] [Related]

  • 9. Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT.
    Nahmias C, Hanna WT, Wahl LM, Long MJ, Hubner KF, Townsend DW.
    J Nucl Med; 2007 May 17; 48(5):744-51. PubMed ID: 17475962
    [Abstract] [Full Text] [Related]

  • 10. PET/CT in non-small cell lung cancer staging-promises and problems.
    Devaraj A, Cook GJ, Hansell DM.
    Clin Radiol; 2007 Feb 17; 62(2):97-108. PubMed ID: 17207691
    [Abstract] [Full Text] [Related]

  • 11. 11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma.
    Nomori H, Shibata H, Uno K, Iyama K, Honda Y, Nakashima R, Sakaguchi K, Goya T, Takanami I, Koizumi K, Suzuki T, Kaji M, Horio H.
    J Thorac Oncol; 2008 Dec 17; 3(12):1427-32. PubMed ID: 19057268
    [Abstract] [Full Text] [Related]

  • 12. Adaptive Neoadjuvant Chemotherapy Guided by (18)F-FDG PET in Resectable Non-Small Cell Lung Cancers: The NEOSCAN Trial.
    Chaft JE, Dunphy M, Naidoo J, Travis WD, Hellmann M, Woo K, Downey R, Rusch V, Ginsberg MS, Azzoli CG, Kris MG.
    J Thorac Oncol; 2016 Apr 17; 11(4):537-44. PubMed ID: 26724474
    [Abstract] [Full Text] [Related]

  • 13. False negative F-18 FDG PET/CT in nonsmall cell lung cancer bone metastases.
    An YS, Yoon JK, Lee MH, Joh CW, Yoon SN.
    Clin Nucl Med; 2005 Mar 17; 30(3):203-4. PubMed ID: 15722832
    [No Abstract] [Full Text] [Related]

  • 14. Prognosis and reevaluation of lung cancer by positron emission tomography imaging.
    Erasmus JJ, Rohren E, Swisher SG.
    Proc Am Thorac Soc; 2009 Apr 15; 6(2):171-9. PubMed ID: 19349485
    [Abstract] [Full Text] [Related]

  • 15. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
    Gondi V, Bradley K, Mehta M, Howard A, Khuntia D, Ritter M, Tomé W.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):187-95. PubMed ID: 17189070
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pulmonary hypertrophic osteoarthropathy in a patient with nonsmall cell lung cancer: Diagnosis with FDG PET/CT.
    Strobel K, Schaefer NG, Husarik DB, Hany TF, Steinert H.
    Clin Nucl Med; 2006 Oct 01; 31(10):624-6. PubMed ID: 16985370
    [No Abstract] [Full Text] [Related]

  • 19. Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.
    Lee HY, Lee HJ, Kim YT, Kang CH, Jang BG, Chung DH, Goo JM, Park CM, Lee CH, Kang KW.
    J Thorac Oncol; 2010 Apr 01; 5(4):497-503. PubMed ID: 20195167
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.